Farallon Capital Management’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $192K | Hold |
12,000
| – | – | ﹤0.01% | 116 |
|
|
2025
Q1 | $205K | Hold |
12,000
| – | – | ﹤0.01% | 114 |
|
|
2024
Q4 | $297K | Hold |
12,000
| – | – | ﹤0.01% | 107 |
|
|
2024
Q3 | $342K | Hold |
12,000
| – | – | ﹤0.01% | 111 |
|
|
2024
Q2 | $317K | Buy |
+12,000
| New | +$317K | ﹤0.01% | 111 |
|
|
2024
Q1 | – | Sell |
-341,000
| Closed | -$14.4M | – | 180 |
|
|
2023
Q4 | $14.4M | Sell |
341,000
-163,000
| -32% | -$6.87M | 0.07% | 72 |
|
|
2023
Q3 | $19.3M | Buy |
+504,000
| New | +$19.3M | 0.09% | 74 |
|